Denis Krutko, MD
Rheumatology · Salt Lake City, UTNPI 1457903064
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.4% of the total across 59 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 15 manufacturers, the largest accounting for just 19.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,674, more than ten times the $12 reported in 2019.
Across 59 payments — averaging $36.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$415
- Amgen$401
- Johnson & Johnson$287
- Novartis$287
- AstraZeneca$262
- AbbVie$231
- plus $252 from 9 others
What the payments were for
- Food & beverage$2,03795%
- Education$995%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 19 | $415 |
| Amgen | 12 | $401 |
| Johnson & Johnson | 4 | $287 |
| Novartis | 5 | $287 |
| AstraZeneca | 2 | $262 |
| AbbVie | 5 | $231 |
| Boehringer Ingelheim | 2 | $45 |
| Genentech USA, Inc. | 2 | $39 |
| ANI Pharmaceuticals, Inc. | 2 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $27 |
| Pharming Healthcare, Inc. | 1 | $22 |
| Sanofi | 1 | $22 |
| Pfizer | 1 | $22 |
| Mallinckrodt Hospital Products Inc. | 1 | $21 |
| Siemens Medical Solutions USA, Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,136 in reported general payments places this provider in the 65th percentile of 52 rheumatology providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 17 | $198,704 |
| Hydroxychloroquine Sulfate | 29 | $1,315 |
| Mycophenolate Mofetil | 13 | $773 |
| MethotrexateMethotrexate Sodium | 16 | $375 |
| Prednisone | 42 | $257 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Salt Lake City
- Catherine BakewellSalt Lake City$1M
- Curry KoeningSalt Lake City$59K
- Javier RiosSalt Lake City$2K
- Tawnie BraatenSalt Lake City$871
- Michael BessenSalt Lake City$586
- Swetha Ann AlexanderSalt Lake City$432
- Srikar SamaSalt Lake City$349
- Dalia SriwiSalt Lake City$349
- Julie ThomasSalt Lake City$260
- Daniel CleggSalt Lake City$178
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.